PRESS RELEASE published on 01/18/2024 at 15:03, 10 months 2 days ago 1upHealth Commits to Supporting Health Plan Compliance with Latest CMS Interoperability Rule 1upHealth, the leading FHIR® platform provider for claims & clinical data acquisition, exchange & compute, is offering support to health plans to comply with the new CMS Interoperability and Prior Authorization final rule for MA Organizations, Medicaid and CHIP Managed Care and State Agencies, FFE QHP Issuers, MIPS Eligible Clinicians, Eligible Hospitals and CAHs Rule (CMS-0057). With their unmatched regulatory expertise in FHIR APIs, 1upHealth aims to guide payers and the broader healthcare industry toward compliance with the new rule ahead of the January 2027 deadline. The company will leverage its end-to-end FHIR data platform, cloud architecture, and years of experience to assist health plans in meeting the forthcoming mandates. 1upHealth FHIR Platform Healthcare Industry CMS Interoperability Prior Authorization
PRESS RELEASE published on 01/09/2024 at 16:15, 10 months 11 days ago 1upHealth Reports 2023 as Record Year of Growth; Company Now Offers Largest Set of CMS APIs in the Industry 1upHealth, the leading FHIR platform for healthcare data acquisition and computation, highlights its significant growth and industry leadership in 2023. With substantial funding, product enhancements, and numerous accolades, including rankings on prestigious lists and awards, 1upHealth continues to drive greater interoperability in the healthcare industry. Supported by its advanced technology and expert team, the company is well-positioned to guide clients through the evolving landscape of healthcare interoperability. Through its achievements, 1upHealth remains committed to advancing standardized data and contributing to the improvement of healthcare outcomes. 1upHealth FHIR Platform Interoperability Healthcare Industry Data Access
Published on 11/21/2024 at 13:30, 29 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 29 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 59 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 59 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 59 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 24 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 44 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 1 minute ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 39 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 14 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo